By blocking paracellular phosphate transport, tenapanor added to phosphate binders may improve the hyperphosphatemia management in patients on maintenance dialysis, a study found.
The proportion of hemodialysis patients with congestive heart failure was 21% for those living below 1000 feet vs 19% and 13% for those living at 1000 to 4000 feet and above 4000 feet, respectively, a study found.
Patients with low BMI had higher mortality risk even at higher spKt/V compared with patients with normal BMI and target range spKt/V of 1.2 to less than 1.4.
In a study of new dialysis patients, low proteinuria was associated with nearly triple the risk for early mortality compared with relatively normal proteinuria.